Other medicaments with >=2 constituents, not fo
HS-Code 300390
Supply Chain Analysis
104 entities · 2024 · exports
Source Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
European Union
$2.79B
19.48% share
Portugal
$2.03B
14.18% share
Ireland
$1.08B
7.51% share
Few dominant players — high dependency risk.
Share Split
Top Exporting Countries
| # | Country | Share | Value | 1Y Growth | 3Y Growth | Signal |
|---|---|---|---|---|---|---|
| 1 | European Union | 19.48% | $2.79B | +10.83% | +137.13% | 🐢 Slowing |
| 2 | 14.18% | $2.03B | +47.92% | +992.60% | 🐢 Slowing | |
| 3 | 7.51% | $1.08B | +124.17% | +599.36% | 🐢 Slowing | |
| 4 | 7.40% | $1.06B | -12.03% | +663.70% | ⚠ Momentum Lost | |
| 5 | 6.79% | $0.97B | -8.61% | -5.76% | 📉 Sustained Drop |
Top Importing Countries
| # | Country | Share | Value | 1Y Growth | 3Y Growth | Signal |
|---|---|---|---|---|---|---|
| 1 | 16.93% | $1.90B | -0.85% | +220.97% | ⚠ Momentum Lost | |
| 2 | 12.21% | $1.37B | -30.06% | +1102.38% | ⚠ Momentum Lost | |
| 3 | 11.20% | $1.26B | -18.26% | +187.33% | ⚠ Momentum Lost | |
| 4 | 9.11% | $1.02B | -17.28% | +1629.76% | ⚠ Momentum Lost | |
| 5 | 6.21% | $0.70B | +221.72% | +402.00% | 🐢 Slowing |
Value vs YoY Growth
Bubble size = market share · Right + Up = high value, high growth
Demand Market Analysis
134 entities · 2024 · imports
Buyer Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
United States
$1.90B
16.93% share
Canada
$1.37B
12.21% share
Germany
$1.26B
11.2% share
Few dominant players — high dependency risk.
Share Split
Global Trade Map
Exports + Imports by country (hover for details)
Explore more products
Access full trade data across our entire product database.
Have an account? Sign in